Health  Vol.7 No.4 , April 2015
Prevalence and Risk Factors of Hepatitis B Virus in Jazan Region, Saudi Arabia: Cross-Sectional Health Facility Based Study
ABSTRACT
Objectives: The objectives of this study were to estimate the prevalence of the HBV infection in Jazan, Kingdom of Saudi Arabia (KSA) and to correlate serologic findings with epidemiological data and known risk factors. Methods: Cross-sectional study conducted in 10 health facilities Jazan province. Study participants (2041) were interviewed using a structured questionnaire. HBsAg was tested in the blood samples collected from the study participants using commercially available kits. Results: The overall prevalence of hepatitis B among study participants was 8.3% (95% CI: 7.2 - 9.6). The prevalence of HBsAg was found to be the highest (22.4%) among those who were over 60 years old (95% CI: 13.2 - 35.0). For participants under 20 years old, the prevalence was the lowest, at only 2.5%. For males the HBV prevalence was 11.2% (95% CI: 9.3 - 13.3), compared to 7.0% (95 CI: 5.5% - 8.8%) for females. Subjects with a family history of HBV (p = 0. 002) and dental procedures (p = 0.008) were found to be associated with higher risk for HBV infection. Conclusion: The prevalence of HBsAg in adults in Jazan remains highly relative to KSA national level. Results showed a marked reduction in HBV among participants under 20 years old. This could be mainly attributed to the successful implementation of the children’s HB immunization programs in the region. Additional efforts to control HBV and vaccination for adults are highly recommended.

Cite this paper
Ageely, H. , Mahfouz, M. , Gaffar, A. , Elmakki, E. , Elhassan, I. , Yasin, A. and Bani, I. (2015) Prevalence and Risk Factors of Hepatitis B Virus in Jazan Region, Saudi Arabia: Cross-Sectional Health Facility Based Study. Health, 7, 459-465. doi: 10.4236/health.2015.74054.
References
[1]   Centers for Disease Control and Prevention. Hepatitis B Information for Health Professionals.
http://www.cdc.gov/hepatitis/HBV/index.htm

[2]   Perz, J.F., Armstrong, G.L., Farrington, L.A., Hutin, Y.J. and Bell, B.P. (2006) The Contributions of Hepatitis B Virus and Hepatitis C Virus Infections to Cirrhosis and Primary Liver Cancer Worldwide. Journal of Hepatology, 45, 529-538.
http://dx.doi.org/10.1016/j.jhep.2006.05.013

[3]   Pollicino, T. and Saitta, C. (2014) Occult Hepatitis B Virus and Hepatocellular Carcinoma. World Journal of Gastroenterology, 20, 5951-5961.
http://dx.doi.org/10.3748/wjg.v20.i20.5951

[4]   World Health Organization (WHO) Factsheet. Hepatitis B, Factsheet Number 204-July 2014.
http://www.who.int/mediacentre/factsheets/fs204/en/

[5]   Alter, M.J. (2003) Epidemiology of Hepatitis B in Europe and Worldwide. Journal of Hepatology, 39, S64-S69.
http://dx.doi.org/10.1016/S0168-8278(03)00141-7

[6]   Al-Wayli, H.M. (2009) Prevalence of Hepatitis B Surface Antigen in a Saudi Hospital Population. Saudi Medical Journal, 30, 448.

[7]   Alshabanat, A.A., Albacker, R.B., Basalama, A.A., Salamah, A.A.B. and Saleh Alfrayh, A. (2013) Profile of Viral Hepatitis in Saudi Arabia. Biomedical Research, 24, 396-399.

[8]   Al-Faleh, F.Z. (2003) Changing Pattern of Hepatitis Viral Infection in Saudi Arabia in the Last Two Decades. Annals of Saudi Medicine, 23, 367-371.

[9]   Arya, S.C., Ashraf, S.J., Parande, C.M., El-Sayed, M., Sahay, R., Ageel, R. and Tobeiqi, M.S. (1985) Hepatitis B Virus in Jizan, Saudi Arabia. Journal of Medical Virology, 17, 267-274.
http://dx.doi.org/10.1002/jmv.1890170308

[10]   E-Hazmi, M.A. (1989) Hepatitis B Virus in Saudi Arabia. Journal of Tropical Medicine and Hygiene, 92, 56-61.

[11]   Abdullah, S.M. (2013) Prevalence of Hepatitis B and C in Donated Blood from the Jazan Region of Saudi Arabia. The Malaysian Journal of Medical Sciences: MJMS, 20, 41-46.

[12]   Ashraf, S.J., Arya, S.C., El-Sayed, M., Sahay, R., Parande, C.M., Tajuddin, M.R., et al. (1986) A Profile of Primary Hepatocellular Carcinoma Patients in the Gizan Area of Saudi Arabia. Cancer, 58, 2163-2168.
http://dx.doi.org/10.1002/1097-0142(19861101)58:9<2163::AID-CNCR2820580934>3.0.CO;2-2

[13]   Parande, C.M., Arya, S.C. and Ashraf, S.J. (1986) Hepatitis B Virus among Saudi Children in Gizan, Saudi Arabia. Infection, 14, 223-225.
http://dx.doi.org/10.1007/BF01644267

[14]   Shepard, C.W., Simard, E.P., Finelli, L., Fiore, A.E. and Bell, B.P. (2006) Hepatitis B Virus Infection: Epidemiology and Vaccination. Epidemiologic Reviews, 28, 112-125.
http://dx.doi.org/10.1093/epirev/mxj009

[15]   Alswaidi, F.M. and O’Brien, S.J. (2010) Is There a Need to Include HIV, HBV and HCV Viruses in the Saudi Premarital Screening Program on the Basis of Their Prevalence and Transmission Risk Factors? Journal of Epidemiology & Community Health, 64, 989-997.
http://dx.doi.org/10.1136/jech.2009.093302

[16]   Hou, J., Liu, Z. and Gu, F. (2005) Epidemiology and Prevention of Hepatitis B Virus Infection. International Journal of Medical Sciences, 2, 50-57.
http://dx.doi.org/10.7150/ijms.2.50

[17]   Wasley, A., Kruszon-Moran, D., Kuhnert, W., Simard, E.P., Finelli, L., McQuillan, G. and Bell, B. (2010) The Prevalence of Hepatitis B Virus Infection in the United States in the Era of Vaccination. Journal of Infectious Diseases, 202, 192-201.
http://dx.doi.org/10.1086/653622

[18]   Yu, A.S., Cheung, R.C. and Keeffe, E.B. (2004) Hepatitis B Vaccine. Clinics in Liver Disease, 8, 283-300.
http://dx.doi.org/10.1016/j.cld.2004.02.010

[19]   Chang, M.H. (2003) Decreasing Incidence of Hepatocellular Carcinoma among Children Following Universal Hepatitis B Immunization. Liver International, 23, 309-314.
http://dx.doi.org/10.1034/j.1478-3231.2003.00865.x

[20]   Al-Faleh, F.Z., Ayoola, E.A., Al-Jeffry, M., Arif, M., Al-Rashed, R.S. and Ramia, S. (1993) Integration of Hepatitis B Vaccine into the Expanded Program of Immunization: The Saudi Arabian Experience. Annals of Saudi Medicine, 13, 231-236.

[21]   Department of Statistics and Information, KSA; 2010-1431 Population Census Preliminary Results [Online].
http://www.cdsi.gov.sa/

[22]   ACON Laboratories, Inc, USA. (2001) ACON HCV. One Step Hepatitis C Virus Test Strip. San Diego, s.n., R015039.

[23]   Ayoola, A.E., Tobaigy, M.S., Gadour, M.O., Ahmad, B.S., Hamza, M.K. and Ageel, A.M. (2003) The Decline of Hepatitis B Viral Infection in South-Western Saudi Arabia. Saudi Medical Journal, 24, 991-995.

[24]   Abdo, A.A., Sanai, F.M. and Al-Faleh, F.Z. (2012) Epidemiology of Viral Hepatitis in Saudi Arabia: Are We Off the Hook? Saudi Journal of Gastroenterology, 18, 349-357.
http://dx.doi.org/10.4103/1319-3767.103425

[25]   Al-Faleh, F.Z., Ayoola, E.A., Arif, M., Ramia, S., al-Rashed, R., Al-Jeffry, M., Al-Mofarreh, M., Al-Karawi, M. and Al-Shabrawy, M. (1992) Seroepidemiology of Hepatitis B Virus Infection in Saudi Arabian Children: A Baseline Survey for Mass Vaccination against Hepatitis B. Journal of Infection, 24, 197-206.
http://dx.doi.org/10.1016/0163-4453(92)93006-C

[26]   Pereira, L.M., Martelli, C.M., Merchán-Hamann, E., Montarroyos, U.R., Braga, M.C., de Lima, M.L., et al. (2009) Population-Based Multicentric Survey of Hepatitis B Infection and Risk Factor Differences among Three Regions in Brazil. The American Journal of Tropical Medicine and Hygiene, 81, 240-247.

[27]   Al-Shamahy, H.A. (2000) Prevalence of Hepatitis B Surface Antigen and Risk Factors of HBV Infection in a Sample of Healthy Mothers and Their Infants in Sana’a, Yemen. Annals of Saudi Medicine, 20, 464-467.

 
 
Top